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Open access under the ElseviPolymorphisms present in the ﬁrst intron of IFN-c may have an important role in the regulation of the
immune response, which could have functional consequences for gene transcription. Leprosy patients
are characterized by different immune responses in different clinical forms. We investigated a possible
association of the +874 polymorphism and CA repeats present in the ﬁrst intron of IFN-c with suscepti-
bility to leprosy and with the manifestation of the different clinical forms. Nucleotide sequencing was
performed with samples from 108 leprosy patients and 113 controls subjects, as well as immunopheno-
typing of CDþ4 , CD
þ
8 and CD
þ
69 T cells by ﬂow cytometry. The data showed that there were no signiﬁcant
differences between patients and control subjects, as well as according classiﬁcation of Ridley–Jopling.
However, the A/A genotype was signiﬁcantly increased in paucibacillary patients (p = 0.028) and the
microsatellite encoding 16 CA repeats were signiﬁcantly associated with paucibacillary compared to mul-
tibacillary patients (p = 0.019). Individuals homozygous for the +874 A allele, the mean level of CDþ4 and
CDþ69 T cells was higher. Our data suggest that polymorphisms present in the ﬁrst intron of IFN-c are not
associated with susceptibility to leprosy, nevertheless, the +874 polymorphism and the CA repeats num-
ber encoded in IFN-c gene may be related to a higher cellular immune response in patients and are con-
sistently more frequently detected in PB patients.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Leprosy is an infectious disease characterized by different clin-
ical forms that are associated with the type of immune response
against Mycobacterium leprae. Patients with the tuberculoid form
present a higher cellular immune response, while those with the
lepromatous show an increased humoral immune response [1].
The cytokine IFN-c plays an important role in the activation of
NK cells and induction of Th-1 cells in the development of the host
immune response [2].
The IFN-c gene is located on chromosome 12q14.1 and consists
of four exons with three intervening introns over approximately
six kilobases (kb). Although few genetic polymorphisms have been
characterized at this locus, some polymorphisms were described in
the non-coding region [3]. To our knowledge the ﬁrst report of an
IFN-c polymorphism, a CA microsatellite in the ﬁrst intron of theral do Amazonas, Instituto de
eneral Rodrigo Octávio Jordão
, Coroado I, CEP 69077-000,
la).
er OA license.gene that was associated with cytokine levels, was detected by
Pravica et al. [4]. In their study, the authors observed higher
IFN-c expression when 2 alleles encoding 12 CA repeats were pres-
ent in the genome. A second study demonstrated an absolute cor-
relation of 12 CA repeat with the +874 T allele. However, the +874
single-nucleotide polymorphism (SNP) has also been related to
IFN-c production [5].
The +874 SNP coincides with the binding site for the transcrip-
tion factor NF-jB [6], therefore, this SNP may have an important
role in the regulation of immune responses by affecting NF-jB-
mediated transcription of the IFN-c gene. The NF-jB motif is
ANTYYC, with N representing any nucleotide and Y representing
a cytosine or thymine [7]. When the +874 T allele is present, the
sequence AATCTC is close to the +874 SNP. However, the +874
T/A polymorphism can affect IFN-c levels when the A allele is pres-
ent, the binding site of NF-jB is altered [5]. This polymorphism has
been associated with tuberculosis [8–10] and toxoplasmosis sus-
ceptibility [11]. Individuals from Brazil and Spain with the +874
A/A genotype express lower IFN-c levels than those with the A/T
and T/T genotypes [8,12]. In different states of Brazil, such as Minas
Gerais [13], Paraná [14] and Rio de Janeiro [15], the A allele is more
494 G.A.V. Silva et al. / Cytokine 60 (2012) 493–497frequently found in the population. Accordingly to those data, our
hypothesis is that this +874 A/A genotype is associated with the
low cellular response observed in multibacillary patients. In the
present study, we investigated whether the +874 T/A SNP and
the microsatellite CA repeats are associated with susceptibility to
leprosy or with the clinical leprosy form that develops in patients
from Amazonas state, Brazil.2. Study subjects and methods
2.1. Study population
The case-control study consisted of 108 patients with leprosy
and 113 control subjects between 18 and 65 years of age. All par-
ticipants were recruited at Fundação de Dermatologia e Venereolo-
gia Alfredo da Matta (FUAM), a tertiary health facility located in
Manaus, Amazonas, Brazil. All included patients were born in the
Brazilian Legal Amazon states. Informed consent was obtained
from all participants and the study was approved by the institu-
tional Ethical Committee.
Experienced professionals from FUAM performed the leprosy
diagnosis using clinical evaluation methods, which included bacte-
riological and histological tests. Patients with leprosy were classi-
ﬁed based on clinical and histological criteria according to the
Ridley–Jopling classiﬁcation system and were also classiﬁed as
paucibacillary (PB) or as multibacillary (MB). PB leprosy is charac-
terized by the presence of 65 skin lesions and a bacteriologic index
(BI) of 0, the classiﬁcation is further subdivided into indeterminate
(I), tuberculoid (TT) or borderline tuberculoid (BT) leprosy. MB lep-
rosy is characterized by the presence of >5 skin lesions and a BI >0,
the classiﬁcation can be further histologically characterized as
mid-borderline (BB), borderline lepromatous (BL), or lepromatous
(LL) leprosy. Pregnant women were excluded from the study, as
well as patients with any diagnosed immunodeﬁciency.
The controls were examined clinically and consisted of geneti-
cally unrelated individuals. Individuals with any immunodeﬁ-
ciency, infectious disease or a family history of leprosy were not
included.
2.2. Biological material
The peripheral blood of control individuals and patients was
collected and used for ﬂow cytometry and DNA extraction using
the Wizard Genomic DNA Puriﬁcation Kit, according to manufac-
turer’s instructions (Promega, Madison, Wisconsin). After elution,
DNA was stored at 80 C until use.
2.3. Polymerase chain reaction – PCR
Approximately 50–200 ng of DNA from each sample was used
for PCR. We designed the forward primer with the sequence
50-TCGTTGCTCACTGGGATTTTG-30. The reverse primer used was
identical to one reported by Bozzi et al. [13], with the sequence
50-CATCTACTGTGCCTTCCTGT-30. The ampliﬁed 322 bp products
were separated by electrophoresis with a 2% agarose gel.
2.4. Puriﬁcation of PCR products and nucleotide sequencing
The PCR product was puriﬁed with theWizard SV Kit (Promega,
Madison, Wisconsin), and approximately 3–10 ng of DNA was used
in the sequencing reaction. Sequencing was performed using Big-
Dye Terminator v3.1 Cycle Sequencing (Applied Biosystems, Foster
City, California) with same primers used in the PCR. Capillary elec-
trophoresis was performed using the ABI 3130 DNA sequencer and
polymer POP-7™.2.5. Sequence analysis
The sequences were initially analyzed using the Sequencing
Analysis (Applied Biosystems, v5.3.1) software and were further
analyzed with SeqMan (DNASTAR Lasergene, v7.0) software to gen-
erate contigs and for comparison with the IFN-c reference gene se-
quence (GenBank ID: J00219).2.6. Flow cytometry analysis
Flow cytometry was performed using ﬂuorochrome-conjugated
antibodies against cell surface antigens to identify the T cells as
CDþ4 T cells (CD3
+ and CDþ4 ), CD
þ
8 T cells (CD3
+ and CDþ8 ) or activated
T cells (CD3+ and CD
þ
69) (Becton–Dickinson, California). The popula-
tion of T cells was identiﬁed and gated, and 10,000 events were ac-
quired for each sample. The samples were analyzed in FACS Calibur
ﬂow cytometer (Becton–Dickinson Immunocytometry Systems,
Palo Alto, California) using CellQuest (v.3.1) software.2.7. Statistical analysis
The Mann–Whitney test and the v2 test were used to compare
the variation in age and sex between the patients and control sub-
jects, respectively. The genotype and allele frequencies present in
each population were initially determined by direct counting; v2
tests were then performed to compare these factors between pa-
tients and control subjects and between paucibacillary (PB) and
multibacillary (MB) patients as well as to compare allele frequency
between PB and MB patients. The G test was used to compare
genotype frequency and the microsatellite distribution between
PB and MB patients. The v2 test was applied to each population
to investigate the Hardy–Weinberg equilibrium. The odds ratio
(OR) and p values were calculated using BioEstat (v.5.2) software.
A t test was used to compare the T-cell subsets using GraphPad
Prism (v.5.0) software. p values less than 0.05 were considered
signiﬁcant.3. Results
3.1. Study population
The participants were all born in the Brazilian Legal Amazon
states and each had at least a third degree of kinship from the re-
gion. There were no differences between patient and control sub-
jects with regard to age, but gender was skewed, with a high
prevalence of male patients. The distribution of patients with PB
or MB is similar, with 49.1% and 50.9%, respectively (Table 1).3.2. Genotype and allele frequencies of the IFN-c +874 A/T
polymorphism
The distribution of genotypes in patient and control subjects is
at Hardy–Weinberg equilibrium (Table 2). The IFN-c +874 A/A and
A/T genotypes were more often found than the T/T genotypes in
both control and leprosy patients. Signiﬁcantly increased frequen-
cies of the IFN-c +874 A/A genotype were noted in PB (p = 0.028,
Table 3), as well as in patients with the TT and BT forms (data
not shown). No signiﬁcant differences the Ridley–Jopling classiﬁca-
tion was observed between variant genotypes.
Allele frequencies for IFN-c +874 are given in Table 3. Allele fre-
quencies did not differ signiﬁcantly between leprosy patients (clas-
siﬁed using Ridley–Jopling) and healthy individuals. Additionally,
there were no differences observed between PB and MB patients.
Strikingly, the data indicated that individuals T carriers +874 locus
Table 1
Characteristics of the study population.
Patients (n = 108) Controls (n = 113)
Age (years) n (%) n (%)
Mean 36.4 ± 13.1 36.2 ± 12.1
Gender
Male 69 (63.9) 42 (37.2)
Female 39 (36.1) 71 (62.8)
Operational classiﬁcation
PB 53 (49.1)
MB 55 (50.9)
Ridley–Jopling
TT 9 (8.3)
BT 28 (25.9)
BB 7 (6.5)
BV 19 (17.6)
VV 29 (26.8)
Tuberculoid (TT); Borderline-Tuberculoid (BT); Mid-Borderline (BB); Borderline-
Lepromatous (BL); Lepromatous (LL). Mann Whitney Test for age between patients
and control subjects p > 0.05; v2 test for gender p < 0.0001.
Table 2
Distribution of genotypes and alleles of +874 IFN-c in leprosy patients and control
subjects.
Genotype/allele N (frequency)
Patients Controls OR (95% IC)
A/A 65 (60.2) 61 (53.9) 1.29 (0.76–2.20)
A/T 33 (30.6) 43 (38.1) 0.72 (0.41–1.25)
T/T 10 (9.2) 9 (8) 1.18 (0.46–3.02)
A 163 (75.5) 147 (73) 1.28 (0.83–1.96)
T 53 (24.5) 61 (27) 0.78 (0.51–1.20)
T carriers 43 (39.8) 52 (46.1) 0.77 (0.45–1.32)
v2 Test with contingency table for genotype and allele between patients and control
subjects, p > 0.05.
Table 3
Distribution of genotypes and alleles of +874 de IFN-c between PB and MB patients.
Genotypea/alleleb N (frequency)
PB patients MB patients OR (95% IC)
A/A 35 (66.1)c 30 (54.5)d 1.62 (0.74–3.53)
A/T 13 (24.5) 20 (36.4) 0.57 (0.25–1.31)
T/T 5 (9.4) 5 (9.1) 1.04 (0.28–3.83)
A 83 (78.3) 80 (72.7) 1.35 (0.73–2.53)
T 23 (21.7) 30 (27.3) 0.74 (0.40–1.38)
T carriers 18 (33.9)c 25 (45.5)d 0.62 (0.28–1.34)
a G Test for genotype between PB and MB patients, p = 0.089.
b v2 Test with contingency table for allele between PB and MB patients, p = 0.427.
c v2 Test for A/A genotype compared T carriers in PB patients, p = 0.028.
d v2 Test for A/A genotype compared T carriers in MB patients, p = 0.589.
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leprosy patients and controls (Table 2).3.3. IFN-c +874 A/T polymorphism and T-cell subsets
We observed a similar distribution of CDþ8 T cells between geno-
types (data not shown); however, a higher median of CDþ4 T cells
(Fig. 1A), as well as activated T cells (Fig. 1B) was found in individ-
uals homozygous for the +874 A allele.3.4. +875 CA repeats
Five alleles were identiﬁed with 12–16 CA repeats after the
+874 polymorphism. A larger number of encoded CA repeats wasassociated with an increased risk of leprosy development, as indi-
cated by the OR data (Table 4).
Allele 2 is found more frequently in control subjects than in pa-
tients (Table 4); however, no signiﬁcant difference was observed.
Signiﬁcant differences were not observed between the clinical
forms of leprosy, but allele 6 (encoding 16 repeats) was associated
with PB patients (Table 5).4. Discussion
IFN-c is an important cytokine that mediates activation of in-
nate immune cells and the development of an adaptive immune re-
sponse [2]. It has been observed that a robust cellular response can
lead to nerve damage in leprosy patients [16]. Previous studies
have associated polymorphisms present in the ﬁrst intron of the
IFN-c gene with cytokine levels in healthy subjects [4,5] and tuber-
culosis patients [8,12].
Some genetic polymorphisms have different outcomes in ethni-
cally distinct populations [15,17–18]. All participants included in
this study were diligently conﬁrmed to be native to location stud-
ied, thus avoiding a genetically heterogeneous population. Age can
be directly related to the development of leprosy, as older individ-
uals have a higher risk of developing the disease [19]. To avoid this
complication, the populations examined in this study were of a
similar age (Table 1).
We observed a higher frequency of the +874 A/A and A/T geno-
types, both in patients and control subjects, similar to what has
been reported in other studies, including England [5], China [20],
Japan [21], Brazil [22] and India [23], indicating similarities on dif-
ferent continents. In Brazil, the allelic frequency among patients is
in agreement with previous studies performed in Minas Gerais
[13], Paraná [14] and Rio de Janeiro [15]; thus the A allele appears
to be common in the Brazilian population and may be related to
the high leprosy rates in Brazil. Other studies found that the
+874 A/A genotype was present at a higher frequency in tubercu-
losis patients, whereas heterozygous genotype was more frequent
in controls [8,9,12]. Accordingly, the A/A genotype was most fre-
quently found among leprosy patients and the A/T genotype was
most frequently found in control subjects (Table 2).
The +874 A/T polymorphismwas associatedwith tuberculosis or
disease severity [8,9,12,20,24], in previous studies, individuals
homozygous for the A allele had double the likelihood of developing
tuberculosis compared to heterozygotes [12,20]. Heterozygosity
may play an important role in the transmission of tuberculosis, be-
cause is found in a higher proportion of the healthy and tuberculin-
positive contacts of tuberculosis patients [12]. Our data indicated
that the individuals +874 T carriers demonstrate a 23% resistance
to leprosy, which may suggest that this polymorphism plays an
important role in the innate immune response.
The expression level of genes involved in the innate immune re-
sponse, including the toll-like receptor (TLR), nucleotide oligomer-
ization domain receptor 2 (NOD2) and mannose receptor 1
(MRC1), can affect leprosy susceptibility [25]. The polymorphism
present in the ﬁrst intron of IFN-c may is according with these
genes. Thus, based on our ﬁndings and on previous studies, the
+874 A/A genotype may alter the expression of genes involved in
the innate immune and affect an individual’s susceptibility to M.
leprae because the A/A genotype is present more prevalent in pa-
tients than in control individuals. However, our data does not indi-
cate an association between this genotype and the susceptibility to
leprosy.
Consistently, healthy subjects and tuberculosis patients homo-
zygous for the A allele possess CDþ4 T and CD
þ
8 T cells producing
higher levels of IFN-c [23]. Curiously, MB patients and control sub-
jects showed a similar frequency of genotypes; nevertheless, the
Fig. 1. CDþ4 and CD
þ
69 expressed in T lymphocytes from leprosy patients with AA or T carriers for +874 polymorphism. There were no signiﬁcant differences in the distribution
of CDþ4 and CD
þ
69 T cells in subjects with A/A genotype (n = 27) or T carriers (n = 19). p > 0.05 using t test.
Table 4
Distribution of +875 CA repeats allele between patients and control subjects.
Allele Repeats N (frequency)
Patients Controls OR (IC 95%)
2 12 40 (36.4) 52 (46) 0.67 (0.39–1.15)
3 13 2 (1.8) 3 (2.6) 0.68 (0.11–4.14)
4 14 53 (48.2) 47 (41.6) 1.31 (0.77–2.22)
5 15 2 (1.8) 2 (1.8) 1.03(0.14–7.43)
6 16 13 (11.8) 9 (8) 1.76 (0.70–4.43)
G Test for CA repeats allele between patients and control subjects, p = 0.589.
Table 5
Distribution of +875 CA repeats allele between paucibacillary (PB) and multibacillary
(MB) patients.
Allele Repeats N (frequency)
PB patients MB patients OR (IC 95%)
2 12 17 (32.1) 23 (43.4) 0.62 (0.28–1.36)
3 13 0 (0) 2 (3.8) –
4 14 25 (47.2) 24 (45.2) 1.08 (0.50–2.32)
5 15 0 (0) 2 (3.8) –
6 16 11 (20.7) 2 (3.8) 6.68 (1.40–31.81)
G Test for CA repeats allele between PB and MB patients, p = 0.019.
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cating that this polymorphism could be related to a large cellular
immune response.
A previous study observed different effects of 50 IL12RB2 poly-
morphisms on NK and T cells. A certain combination of SNPs has
been related to increase expression of IL12Rb2 in T cells, while in
NK cells, expression was signiﬁcantly decreased. Possible explana-
tions for these different outcomes include different binding sites
for transcriptional factors in NK compared to T cells [26] and the
expression of speciﬁc and different transcription factors in each
cell type. Our data may in agreement with this ﬁnding, considering
that the A/A genotype may be associated with a higher expression
of IFN-c in T cells but a decrease in NK cells. The +874 A/A geno-
type plays a role in the control of the spread of bacilli; however,
this genotype provides no protect from M. leprae infection.
In previous studies, the +874 A/A genotype and the microsatel-
lite repeat number have been associated with susceptibility to
tuberculosis [20,27]; therefore, is hypothesized that this combina-
tion has differential effects on innate and adaptive immunity. The
+874 polymorphism is associated with a functional motif, and the
A/T and T/T genotypes are associated with higher expression levels
of the cytokine in plasma, demonstrating that the cytokine’s levels
are associated with the number of copies of the T allele [8]. There-
fore, individuals homozygous for the A allele have lower IFN-c lev-
els than those with the A/T and T/T genotypes [12]. Patients with
tuberculosis have lower IFN-c levels than healthy individualsindependent of this genotype [8,28]. The +874 A/A genotype and
16 repeats of the microsatellite may be associated with a large cel-
lular immune response.
The +874 A/A genotype may be involved in the control of infec-
tion by M. leprae, due this genotype was found more frequently in
patients with TT and BT clinical forms (data not shown). Higher
IFN-c production has been observed in subjects homozygous for
the A allele in response to the M. leprae [15]. This observation is
conﬁrmed in this study; we observed IFN-c levels above 10 pg/
mL in patients with the A/A genotype, whereas T carriers patients
had a mean level of 4 pg/mL (data not shown). Higher IFN-c pro-
duction may be related to the number of CDþ4 T cells and activated
T cells (Fig. 1).
Previous studies have shown that allele 2 with 12 CA repeats in
the ﬁrst intron of the IFN-c gene, is associated with higher levels of
cytokine production in vitro [4]. The allele with 11 CA repeats is
present at a low frequency in the general population [4,20]; re-
cently, this ﬁnding has been corroborated [27]. This allele was
not found in this study and may be considered a rare allele. The
+874 T allele is correlated with the microsatellite allele 2 with 12
CA repeats [5] and we suggest that the alleles +874 A and 16 CA re-
peats may be associated with higher IFN-c production and may
have an important role in controlling the spread of M. leprae.
The functional signiﬁcance of the +874 polymorphism has been
observed in different tuberculosis studies, where the T allele is re-
lated to increased cytokine levels [4,5,12]. Though there is some
controversy, the A/A genotype has been observed to lead to higher
IFN-c levels, speciﬁcally in response to M. leprae [15]. In conclu-
sion, our results suggest that the +874 polymorphism is not asso-
ciated with susceptibility to leprosy; however, the combination
of +874 A/A and 16 CA repeats may be associated with a large cel-
lular immune response to M. leprae, based on the higher frequency
detected in PB patients.Financial support
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